Potential teratogenicity of gonadotropin treatment for ovulation induction in the mouse offspring
- 1 October 1987
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 36 (2) , 229-233
- https://doi.org/10.1002/tera.1420360211
Abstract
The teratogenic effects of induced ovulation were studied in mice by using three different doses of pregnant mare's serum (PMS)/human chorionic gonadotropin (HCG) (2.5, 5, or 10 IU) at two different stages of the estrous cycle. The PMS/HCG treatment induced high incidences of external congenital anomalies in the offspring in a dose-dependent manner. This was especially so when the treatment was “out of phase” to the naturally occurring ovulation schedule. The predominant malformations were open eyelids and cleft palate. The problems of extrapolating these findings to humans are discussed.This publication has 21 references indexed in Scilit:
- Sex difference in susceptibility to teratogenic effect of maternal biotin deficiency in mouse embryosTeratology, 1985
- Results of HMG (Humegon)-HCG therapy in 6096 treatment cycles of 2166 Japanese women with anovulatory infertilityEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1985
- Congenital abnormalities and hormones during pregnancy: A clinical reviewTeratology, 1980
- REDUCTION OF DRUG-INDUCED CLEFT PALATE IN MICEThe Lancet, 1975
- Failure of exogenous gonadotrophin controlled ovulation to cause digit abnormalities in miceNature, 1975
- The prenatal development of the mouse eyeThe Anatomical Record, 1970
- Treatment of anovulation with menotropinsJAMA, 1968
- GENETIC AND HORMONAL INFLUENCES ON OVULATION AND IMPLANTATION IN ADULT MICE TREATED WITH GONADOTROPHINSJournal of Endocrinology, 1963
- INDUCTION OF SUPEROVULATION AND PREGNANCY IN MATURE MICE BY GONADOTROPHINSJournal of Endocrinology, 1957
- A Note on the Staining of the Skeleton of Cleared Specimens with Alizarin Red SStain Technology, 1926